Oct 27, 6:17 AM ET
First Horizon Corporation's boards elected Jeffrey R. Balser, a physician and academic health system executive, to the board effective October 26, 2026, and amended the bylaws to increase the board from twelve to thirteen members. The filing reports no financial results, and the changes are governance matters that add one board seat and one new director.
- Jeffrey R. Balser elected to the board effective immediately on October 26, 2026.
- Balser is President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine.
- Balser appointed to the Nominating and Corporate Governance Committee and the Information Technology Committee.
- Bylaw Section 3.2 amended October 26, 2026 to set the board at thirteen members, up from twelve.
Read the filing on SEC.gov ↗
Oct 15, 7:31 AM ET
First Horizon reported a third-quarter 2026 net loss available to common shareholders of $(94) million, or $(0.20) per diluted share, driven by $347 million in after-tax notable items tied to a pending sale of about $4.5 billion of consumer mortgages agreed in early October. Excluding notable items, adjusted diluted EPS was $0.53, down $0.01 from the second quarter, and the sale is expected to settle early in the fourth quarter.
- Notable items totaled $0.73 per share, or $347 million after tax, mainly from reclassifying targeted mortgage loans to held for sale.
- Adjusted diluted EPS was $0.53, down $0.01 from second quarter 2026.
- CET1 capital ratio was a preliminary 10.3%, down from 10.5% in second quarter 2026.
- Average client deposit balances rose $1.3 billion in the quarter.
Read the filing on SEC.gov ↗
Jul 15, 6:32 AM ET
First Horizon reported second quarter 2026 net income available to common shareholders of $260 million, or $0.54 per diluted share, up from $233 million and $0.45 a year earlier. Results improved from the first quarter, when the company reported $257 million and $0.53 per share, and the company's return on common equity was 12.3%.
- Net income available to common shareholders was $260 million, up 12% from $233 million in second quarter 2025.
- Diluted EPS was $0.54, compared with $0.53 in first quarter 2026 and $0.45 in second quarter 2025.
- Noninterest expense rose to $531 million, up $26 million from the prior quarter; the net interest margin was 3.49%, down 3 basis points.
- Share repurchases totaled $100 million at an average price of $24.52 per share, and the CET1 ratio was 10.5%.
Read the filing on SEC.gov ↗
Apr 15, 6:32 AM ET
First Horizon reported first quarter 2026 net income available to common shareholders of $257 million, or $0.53 per diluted share, up from $213 million, or $0.41, a year earlier. Revenue of $862 million rose 6% from the prior-year quarter but fell 3% from the fourth quarter of 2025. The results are a routine quarterly release that shows year-over-year profit growth while the company also reported lower quarter-over-quarter net interest income and noninterest income.
- Net income available to common shareholders was $257 million, up 21% from $213 million in first quarter 2025 and flat with fourth quarter 2025.
- Diluted EPS was $0.53, compared with $0.41 a year earlier and $0.52 in fourth quarter 2025.
- Noninterest expense was $505 million, down $40 million from fourth quarter 2025.
- Share repurchases totaled $233 million at an average price of $24.54 per share, and CET1 ratio was an estimated 10.53%.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
